Titan Medical Inc., a research and development stage company, focuses on the design, development, and commercialization of computer-assisted robotic surgical technologies for application in minimally invasive surgery (MIS). More Details
Limited growth with imperfect balance sheet.
Share Price & News
How has Titan Medical's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: TMD is not significantly more volatile than the rest of Canadian stocks over the past 3 months, typically moving +/- 11% a week.
Volatility Over Time: TMD's weekly volatility has decreased from 71% to 11% over the past year.
7 Day Return
CA Medical Equipment
1 Year Return
CA Medical Equipment
Return vs Industry: TMD exceeded the Canadian Medical Equipment industry which returned 25.5% over the past year.
Return vs Market: TMD exceeded the Canadian Market which returned 39.2% over the past year.
Long-Term Price Volatility Vs. Market
How volatile is Titan Medical's share price compared to the market and industry in the last 5 years?
Simply Wall St News
1 year ago | Simply Wall StTitan Medical (TSE:TMD) Is Very Risky Based On Its Cash Burn
2 years ago | Simply Wall StWhat Kind Of Risk Should You Expect For Titan Medical Inc (TSE:TMD)?
3 years ago | Simply Wall StWhat Can We Expect for Titan Medical Inc (TSX:TMD) Moving Forward?
Is Titan Medical undervalued compared to its fair value and its price relative to the market?
In this section, we usually try to help investors determine whether Titan Medical is trading at an attractive price based on the cash flow it is expected to produce in the future. But as Titan Medical has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions.
This is quite a rare situation as 89% of companies covered by Simply Wall St do have a valuation analysis.
How is Titan Medical forecast to perform in the next 1 to 3 years based on estimates from 2 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: TMD is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: TMD is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: TMD is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: TMD's revenue (22.6% per year) is forecast to grow faster than the Canadian market (6.3% per year).
High Growth Revenue: TMD's revenue (22.6% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if TMD's Return on Equity is forecast to be high in 3 years time
How has Titan Medical performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: TMD is currently unprofitable.
Growing Profit Margin: TMD is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: TMD is unprofitable, but has reduced losses over the past 5 years at a rate of 8.7% per year.
Accelerating Growth: Unable to compare TMD's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: TMD is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (16.2%).
Return on Equity
High ROE: TMD's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.
How is Titan Medical's financial position?
Financial Position Analysis
Short Term Liabilities: TMD has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.
Long Term Liabilities: TMD has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.
Debt to Equity History and Analysis
Debt Level: TMD has negative shareholder equity, which is a more serious situation than a high debt level.
Reducing Debt: TMD's has negative shareholder equity, so we do not need to check if its debt has reduced over time.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: TMD has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: TMD has sufficient cash runway for more than 3 years if free cash flow continues to reduce at historical rates of 0% each year
What is Titan Medical current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate TMD's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate TMD's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if TMD's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if TMD's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of TMD's dividend in 3 years as they are not forecast to pay a notable one for the Canadian market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
David McNally (58 yo)
Mr. David J. McNally has been Chief Executive Officer at Titan Medical Inc. since January 3, 2017 and has been its President since January 9, 2017 and also serves as its Chairman since June 4, 2020. Mr. Mc...
CEO Compensation Analysis
Compensation vs Market: David's total compensation ($USD495.00K) is about average for companies of similar size in the Canadian market ($USD471.71K).
Compensation vs Earnings: David's compensation has been consistent with company performance over the past year.
Experienced Management: TMD's management team is not considered experienced ( 0.9 years average tenure), which suggests a new team.
Experienced Board: TMD's board of directors are not considered experienced ( 0.8 years average tenure), which suggests a new board.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 82.8%.
Titan Medical Inc.'s company bio, employee growth, exchange listings and data sources
- Name: Titan Medical Inc.
- Ticker: TMD
- Exchange: TSX
- Founded: NaN
- Industry: Health Care Equipment
- Sector: Healthcare
- Market Cap: CA$224.532m
- Shares outstanding: 109.53m
- Website: https://www.titanmedicalinc.com
Number of Employees
- Titan Medical Inc.
- 155 University Avenue
- Suite 750
- M5H 3B7
Titan Medical Inc., a research and development stage company, focuses on the design, development, and commercialization of computer-assisted robotic surgical technologies for application in minimally invas...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/05/15 23:57|
|End of Day Share Price||2021/05/14 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.